Status:
RECRUITING
Biospecimen Analysis in Detecting Chemical Concentrations in Patients With Chronic or Infectious Diseases Receiving Meditations
Lead Sponsor:
City of Hope Medical Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Chronic Disease
Infectious Disorder
Eligibility:
All Genders
18+ years
Brief Summary
This trial collects and analyzes sweat and saliva samples compared to blood in detecting chemical concentrations in the body in patients with chronic or infectious diseases receiving medications. Wear...
Detailed Description
PRIMARY OBJECTIVE: I. To compare novel, home-based methods of quantitating medication concentrations in either saliva or sweat to the 'gold standard' of liquid chromatography - mass spectrometry of p...
Eligibility Criteria
Inclusion Criteria:
-
Scheduled to receive medications including, but not limited to, cyclophosphamide, mycophenolic acid, mycophenolate mofetil, metformin or busulfan (any dose, any number of doses, any dosing frequency) as part of treatment at any time. Patients with chronic or infectious diseases can participate
-
Willingness to:
- Provide blood, sweat, and saliva samples
- Permit medical record review
Exclusion Criteria:
- Pilocarpine allergy
- Difficulty with understanding written English
Key Trial Info
Start Date :
November 9 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2029
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04160429
Start Date
November 9 2018
End Date
July 30 2029
Last Update
November 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
City of Hope Medical Center
Duarte, California, United States, 91010